Picture of Taro Pharmaceutical Industries logo

TARO — Taro Pharmaceutical Industries News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid Cap

Brief: Taro Q3 sales USD 157.145 million

Jan 25 (Reuters) - Taro Q3 gross profit USD 79.881 million.
* Q3 operating income USD 15.883 million
* Q3 sales USD 157.145 million
* Q3 net income USD 20.208 million

Recent news on Taro Pharmaceutical Industries

See all news